Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI-enabled Test Selection, a generative AI-enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. The company has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. It also has a collaboration with Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North

CEO

Mr. Adam H. Schechter

Employees

60900

Country

United States

ISIN

US5049221055

Listings

0 Comments

Share your thoughts

FAQ

What is Labcorp stock price today?▼

The current price of LH is $265.03 USD — it has decreased by -0.42% in the past 24 hours. Watch Labcorp stock price performance more closely on the chart.

What is Labcorp stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Labcorp stocks are traded under the ticker LH.

Is Labcorp stock price growing?▼

LH stock has fallen by -2.29% compared to the previous week, the month change is a +5.84% rise, over the last year Labcorp has showed a +0.41% increase.

What is Labcorp market cap?▼

Today Labcorp has the market capitalization of 21.84B

When is the next Labcorp earnings date?▼

Labcorp is going to release the next earnings report on July 30, 2026.

What were Labcorp earnings last quarter?▼

LH earnings for the last quarter are 4.25 USD per share, whereas the estimation was 4.11 USD resulting in a +3.42% surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Labcorp revenue for the last year?▼

Labcorp revenue for the last year amounts to 27.9B USD.

What is Labcorp net income for the last year?▼

LH net income for the last year is 1.75B USD.

Does Labcorp pay dividends?▼

Yes, LH dividends are paid quarterly. The last dividend per share was 0.72 USD. As of today, Dividend Yield (FWD)% is 1.09%.

How many employees does Labcorp have?▼

As of June 16, 2026, the company has 60,900 employees.

In which sector is Labcorp located?▼

Labcorp operates in the Health & Wellness sector.

When did Labcorp complete a stock split?▼

The last stock split for Labcorp was on July 03, 2023 with a ratio of 1164:1000.

Where is Labcorp headquartered?▼

Labcorp is headquartered in Burlington, United States.